Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus
Author(s) -
Bernadette Jakeman,
Alexandra Scherrer,
Katharine Darling,
José Damas,
Mélanie Bieler-Aeschlimann,
Barbara Hasse,
Ladina Schlosser,
Anna Hachfeld,
Klemens Gutbrod,
Philip Tarr,
Alexandra Calmy,
Frédéric Assal,
Ursula Kunze,
Marcel Stoeckle,
Patrick Schmid,
Gianina Toller,
Stefania Rossi,
Caroline Di Benedetto,
Renaud Du Pasquier,
Matthias Cavassini,
Catia Marzolini,
Isaure Nadin,
Peter Brugger,
Andreas U. Monsch,
Ursi Kunze,
Marc Schwind,
Arseny A. Sokolov,
Tobias Derfuß,
Sebastian von Arx,
Günter Eisele,
Manuel Bertschi,
Thomas Hundsberger,
Michael Oberholzer,
Illijas Jelcic,
Leonardo Sacco,
Thanh Lecompte,
Helen Kovari,
Christoph A. Fux,
Enos Bernasconi,
Katharina Darling,
Katharina Kusejko,
Yannick Vallet,
Valerie Sormani,
Bruno Ledergerber,
Isabella Locatelli,
Laurent A. Décosterd,
Cristina Granziera,
Gunnar Krueger,
Reto Meuli,
María Isabel Vargas
Publication year - 2022
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofac457
Subject(s) - medicine , anticholinergic , neurocognitive , human immunodeficiency virus (hiv) , sedative , psychiatry , intensive care medicine , pharmacology , virology , anesthesia , cognition
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom